4//SEC Filing
Grigoriadis Dimitri E. 4
Accession 0001209191-22-006588
CIK 0000914475other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:04 PM ET
Size
7.9 KB
Accession
0001209191-22-006588
Insider Transaction Report
Form 4
Grigoriadis Dimitri E.
Vice President, Research
Transactions
- Award
Restricted Stock Unit
2022-01-31+4,746→ 4,746 total→ Common Stock (4,746 underlying) - Award
Stock Option
2022-01-31+32,319→ 32,319 totalExercise: $79.02Exp: 2032-01-31→ Common Stock (32,319 underlying)
Footnotes (3)
- [F1]Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on February 28, 2022 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
- [F3]The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of January 31, 2023, January 31, 2024, January 31, 2025, and January 31, 2026.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001423838
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 8:04 PM ET
- Size
- 7.9 KB